4lri

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 5: Line 5:
</td></tr><tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4lri FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lri OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4lri RCSB], [http://www.ebi.ac.uk/pdbsum/4lri PDBsum]</span></td></tr>
</td></tr><tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4lri FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lri OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4lri RCSB], [http://www.ebi.ac.uk/pdbsum/4lri PDBsum]</span></td></tr>
<table>
<table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Cytomegalovirus (CMV) is a widespread opportunistic pathogen that causes birth defects when transmitted transplacentally and severe systemic illness in immunocompromised individuals. MSL-109, a human monoclonal IgG isolated from a CMV seropositive individual, binds to the essential CMV entry glycoprotein H (gH) and prevents infection of cells. Here, we suggest a mechanism for neutralization activity by MSL-109. We define a genetic basis for resistance to MSL-109 and have generated a structural model of gH that reveals the epitope of this neutralizing antibody. Using surface-based, time-resolved FRET, we demonstrate that gH/gL interacts with glycoprotein B (gB). Additionally, we detect homodimers of soluble gH/gL heterodimers and confirm this novel oligomeric assembly on full-length gH/gL expressed on the cell surface. We show that MSL-109 perturbs the dimerization of gH/gL:gH/gL, suggesting that dimerization of gH/gL may be required for infectivity. gH/gL homodimerization may be conserved between alpha- and betaherpesviruses, because both CMV and HSV gH/gL demonstrate self-association in the FRET system. This study provides evidence for a novel mechanism of action for MSL-109 and reveals a previously undescribed aspect of viral entry that may be susceptible to therapeutic intervention.
 +
 +
Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.,Fouts AE, Comps-Agrar L, Stengel KF, Ellerman D, Schoeffler AJ, Warming S, Eaton DL, Feierbach B Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8209-14. doi:, 10.1073/pnas.1404653111. Epub 2014 May 19. PMID:24843144<ref>PMID:24843144</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>

Revision as of 06:28, 2 July 2014

Anti CMV Fab Fragment

4lri, resolution 1.65Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Views
Personal tools
Navigation
Toolbox